ABIJKLMNOPQRSTUVWXYZAAABAC
1
Income
31/03/201430/06/201430/09/201431/12/20142014201520162017201820192020
2
Okyanos $ 4,000,000 $ 5,500,000 $ 8,000,000 $ 12,000,000 $ 15,000,000 $ 18,000,000
3
Japan $ 6,000,000 $ 10,000,000 $ 15,000,000 $ 20,000,000 $ 50,000,000 $ 75,000,000
4
Lorem Vascular $ 5,000,000 $ 7,500,000 $ 15,000,000 $ 60,000,000 $ 100,000,000 $ 140,000,000
5
European Union $ 250,000 $ 350,000 $ 850,000 $ 15,000,000 $ 50,000,000 $ 75,000,000
6
Other (including USA) $ 50,000 $ 100,000 $ 1,300,000 $ 30,000,000 $ 100,000,000 $ 150,000,000
7
Product Revenues
 $ 1,031,000 $ 935,000 $ 518,000 $ 3,850,000 $ 6,334,000 $ 15,300,000 $ 23,450,000 $ 40,150,000 $ 137,000,000 $ 315,000,000 $ 458,000,000
8
Cost of Product Revenues
 $ 421,000 $ 766,000 $ 337,000 $ 1,624,700 $ 3,148,700 $ 3,825,000 $ 5,862,500 $ 8,030,000 $ 20,550,000 $ 47,250,000 $ 68,700,000
9
Gross Profit $ 610,000 $ 169,000 $ 181,000 $ 2,225,300 $ 3,185,300 $ 11,475,000 $ 17,587,500 $ 32,120,000 $ 116,450,000 $ 267,750,000 $ 389,300,000
10
59.2%18.1%34.9%57.8%50.3%75.0%75.0%80.0%85.0%85.0%85.0%
11
Development Revenues:
15
Government Contract and other $ 403,000 $ 356,000 $ 585,000 $ 3,730,000 $ 5,074,000 $ 12,000,000 $ 20,000,000 $ 30,000,000 $ 5,000,000 $ 5,000,000 $ 5,000,000
16
Total Development Revenues $ 403,000 $ 356,000 $ 585,000 $ 3,730,000 $ 5,074,000 $ 12,000,000 $ 20,000,000 $ 30,000,000 $ 5,000,000 $ 5,000,000 $ 5,000,000
17
18
Total Revenue $ 1,434,000 $ 1,291,000 $ 1,103,000 $ 7,580,000 $ 11,408,000 $ 27,300,000 $ 43,450,000 $ 70,150,000 $ 142,000,000 $ 320,000,000 $ 463,000,000
19
20
Operating Expenses:
21
Research and Development $ 4,292,000 $ 4,674,000 $ 3,140,000 $ 3,431,600 $ 15,537,600 $ 22,000,000 $ 28,000,000 $ 38,000,000 $ 20,000,000 $ 25,000,000 $ 40,000,000
22
Sales and Marketing $ 1,928,000 $ 1,934,000 $ 1,471,000 $ 950,000 $ 6,283,000 $ 4,000,000 $ 4,000,000 $ 5,000,000 $ 6,000,000 $ 7,000,000 $ 9,000,000
23
General and Administrative $ 4,340,000 $ 4,602,000 $ 4,179,000 $ 3,000,000 $ 16,121,000 $ 10,500,000 $ 11,000,000 $ 15,000,000 $ 15,000,000 $ 17,000,000 $ 20,000,000
26
Total Operating Expenses $ 10,560,000 $ 11,210,000 $ 8,656,000 $ 7,381,600 $ 37,807,600 $ 36,500,000 $ 43,000,000 $ 58,000,000 $ 41,000,000 $ 49,000,000 $ 69,000,000
27
28
Operating Gain (Loss) $ (9,547,000) $ (10,685,000) $ (7,890,000) $ (1,426,300) $ (29,548,300) $ (13,025,000) $ (5,412,500) $ 4,120,000 $ 80,450,000 $ 223,750,000 $ 325,300,000
29
30
Other Income (expense):
33
Interest Income $ 2,000 $ 1,000 $ 1,000 $ 1,000,000 $ 4,000,000 $ 10,000,000
34
Interest Expense $ (941,000) $ (1,085,000) $ (1,260,000) $ (1,260,000) $ (4,546,000) $ (2,650,000) $ (2,650,000) $ (2,650,000) $ (500,000)
35
Other Income (Expense), net $ 86,000 $ (58,000) $ (222,000) $ (222,000) $ (416,000) $ (250,000) $ (250,000) $ (250,000) $ -
38
Total Other Income (Expense) $ (853,000) $ (1,143,000) $ (1,495,000) $ (1,482,000) $ (4,973,000) $ (2,900,000) $ (2,900,000) $ (2,900,000) $ 500,000 $ 4,000,000 $ 10,000,000
39
40
Net Gain (Loss) $ (10,400,000) $ (11,828,000) $ (9,385,000) $ (2,908,300) $ (34,521,300) $ (15,925,000) $ (8,312,500) $ 1,220,000 $ 80,950,000 $ 227,750,000 $ 335,300,000
41
42
Other Income (loss)
43
Foreign Currency Adjustments $ (50,000) $ 193,000 $ 58,000
44
45
Net Comprehensive Gain (Loss)
 $ (10,450,000) $ (11,635,000) $ (9,327,000) $ (2,908,300) $ (34,320,300) $ (15,925,000) $ (8,312,500) $ 1,220,000 $ 80,950,000 $ 227,750,000 $ 335,300,000
46
47
Diluted Net Loss per Common Share
 $ (0.14) $ (0.15) $ (0.12) $ (0.03) $ (0.32) $ (0.10) $ (0.05) $ 0.01 $ 0.45 $ 1.27 $ 1.86
48
49
Diluted Weighted Average Common Shares
 74,102,396 76,682,643 80,430,061 95,000,000 $ 106,400,000 165,000,000 180,000,000 180,000,000 180,000,000 180,000,000 180,000,000
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96